Abstract:Introduction: Many studies identified that smokers had lower body mass index (BMI) than non-smokers, but the underlying mechanisms are not well understood. Hypothesis: An untargeted metabolomics study will identify novel mechanisms underlying smoking associated weight loss. Methods: We performed cross-sectional analyses among all 248 current smokers and 637 never smokers participated in the Bogalusa Heart Study 2016 survey. After stringent quality control and normalization, 1,202 plasma metabolites were assessed for mediation effects on smoking-BMI association after controlling for age, gender, race, education, drinking and physical activity. The collective mediation effects of metabolites were estimated by comparing the smoking-BMI associations before and after controlling for all significant metabolites after Bonferroni correction. Bidirectional Mendelian randomization analyses were then performed on a subset of participants (n=654) to delineate causal directions among smoking, BMI, and significant metabolites. We constructed multi-locus genetic risk scores (GRS) for smoking and BMI based on findings from published GWASs with a sample size of more than 250,000. Multivariable linear regression controlling for the same covariates as in the mediation analyses was used to estimate associations between smoking- and BMI-GRSs and the significant metabolites. Results: Compared to never smokers, current smokers had a 3.31 kg/m 2 (95% confidence interval [CI]: 2.15-4.47) lower BMI after adjusting for all covariables. A total of 40 metabolites significantly mediated and explained 90.7% of the smoking-BMI association. Seven of the significant metabolites were associated with smoking GRS but not BMI GRS, suggesting a true mediation role in the smoking-BMI association. The seven metabolites, including homoarginine (mediation beta=-0.49 kg/m 2 , 95% CI: -0.78 to -0.26), 1-oleoyl-GPE (18:1) (mediation beta=-0.44 kg/m 2 , 95% CI: -0.72 to -0.22), 1-linoleoyl-GPE (18:2)* (mediation beta=-0.59 kg/m 2 , 95% CI: -0.90 to -0.32), beta-cryptoxanthin (mediation beta=0.53 kg/m 2 , 95% CI: 0.27 to 0.83), 1-stearoyl-2-arachidonoyl-GPE (18:0/20:4) (mediation beta=0.39 kg/m 2 , 95% CI: 0.18 to 0.65), sphingomyelin (d18:2/21:0, d16:2/23:0)* (mediation beta=-0.54 kg/m 2 , 95% CI: -0.84 to -0.28), and sphingomyelin (d17:2/16:0, d18:2/15:0)* (mediation beta=-0.92 kg/m 2 , 95% CI: -1.30 to -0.59), mediated 36.3% of the association between current smoking and BMI. We also identified 6 metabolites significantly associated with BMI GRS but not with smoking GRS, and 2 significantly associated with both smoking- and BMI-GRSs. Conclusions: We identified 7 plasma metabolites that mediated a large proportion of the association between smoking and BMI.

The association of smoking with different eating and dietary behaviours: A cross‐sectional analysis of 80 296 United Kingdom adults

Smoking-related gut microbiota alteration is associated with obesity and obesity-related diseases: results from two independent cohorts with sibling comparison analyses

Smoking status and body fatness indicators: a cross-sectional survey among 1948 Chinese male adults

Dietary Patterns among Smokers and Non-Smokers: Findings from the National Health and Nutritional Examination Survey (NHANES) 2017–2018

Associations of Nicotine Dependence and Fat Distribution in Chinese Male Adults: a Cross-Sectional Study in Lanxi, China.

Smoking and body weight: evidence from China health and nutrition survey

Weighing cessation: Rising adiposity of current smokers in NHANES

Weight Status, Quality of Life, and Cigarette Smoking among Adolescents in Washington State

Diet, eating behaviour and weight gain in men and women with overweight/obesity receiving varenicline for smoking cessation

Association of Smoking-Related Knowledge, Attitude, and Practices (KAP) with Nutritional Status and Diet Quality: A Cross-Sectional Study in China

Adiposity-Mortality Relationships in Type 2 Diabetes, Coronary Heart Disease, and Cancer Subgroups in the UK Biobank, and Their Modification by Smoking

Changes in weight among individuals with psychiatric conditions or socioeconomic disadvantage assigned to smoke very low nicotine content cigarettes.

Conditional and Unconditional Genome-Wide Association Study Reveal Complicate Genetic Architecture of Human Body Weight and Impacts of Smoking

Combined health risks of cigarette smoking and low levels of physical activity: a prospective cohort study in England with 12-year follow-up

Weight Gain after Smoking Cessation and Risk of Major Chronic Diseases and Mortality

Association of time spent on social media with youth cigarette smoking and e-cigarette use in the UK: a national longitudinal study

A comprehensive analysis of the health effects associated with smoking in the largest population using UK Biobank genotypic and phenotypic data

Cross-sectional associations of dietary patterns with health status and smoking-related knowledge, attitudes and practices (KAP) among Bangladeshi adolescent smokers

Abstract P111: Untargeted Metabolomics Study And Bidirectional Mendelian Randomization Analyses Identified Novel Metabolites Mediating The Effect Of Current Smoking On Body Mass Index

Smoking-Interaction Loci Affect Obesity Traits: A Gene-Smoking Stratified Meta-Analysis of 545,131 Europeans

Longitudinal patterns of smoking behaviours in adolescence and early adulthood and their association with modifiable and sociodemographic risk factors